Nathalia Rodrigues de Faria Corrêa

Nathalia Rodrigues de Faria Corrêa

Auto-generated profile, based on publicly available information

Nathalia Rodrigues de Faria Corrêa

Hospital de Clínicas de Porto Alegre, Serviço de Endocrinologia, Porto Alegre, RS, Brasil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Genetics and Molecular Biology
Verified
Journal Article
Open access
PDF file
CDCristine Dieter
Cristine Dieter
NLNatália E. Lemos
Natália E. Lemos
EGEliandra Girardi
Eliandra Girardi
DRDenise Taurino Ramos
Denise Taurino Ramos
NCNathalia Rodrigues de Faria Corrêa
Nathalia Rodrigues de Faria Corrêa
DCDaisy Crispim
Daisy Crispim
Long non-coding RNAs (lncRNAs) are RNAs with >200 nucleotides that are unable to encode proteins and are involved in gene expression regulation. LncRNAs have a key role in many physiological and pathological processes and, consequently, they have been associated with several human diseases, including diabetes chronic complications, such as diabetes kidney disease (DKD). In this context, some studies have identified the dysregulation of the lncRNAs MALAT1 and TUG1 in patients with DKD; nevertheless, available data are still contradictory. Thus, the objective of this study was to compare MALAT1 and TUG1 expressions in urine of patients with type 1 diabetes mellitus (T1DM) categorized according to DKD presence. This study comprised 18 T1DM patients with DKD (cases) and 9 long-duration T1DM patients without DKD (controls). MALAT1 and TUG1 were analyzed using qPCR. Bioinformatics analyses were done to identify both lncRNA target genes and the signaling pathways under their regulation. The lncRNA MALAT1 was upregulated in urine of T1DM patients with DKD vs. T1DM controls (P = 0.007). The expression of lncRNA TUG1 did not differ between groups (P = 0.815). Bioinformatics analysis showed these two lncRNAs take part in metabolism-related pathways. The present study shows that the lncRNA MALAT1 is upregulated in T1DM patients presenting DKD.

11 November 2021 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
CDCristine Dieter
Cristine Dieter
NLNatália E. Lemos
Natália E. Lemos
NCNathalia Rodrigues de Faria Corrêa
Nathalia Rodrigues de Faria Corrêa
ACAline Rodrigues Costa
Aline Rodrigues Costa
LCLuís Henrique Canani
Luís Henrique Canani
ABAndrea C. Bauer
Andrea C. Bauer
Objective: As studies have reported the involvement of angiopoietin-2 (ANGPT-2) in the pathogenesis of diabetic retinopathy (DR), the aim of this study was to investigate the association between the ANGPT-2 rs2442598 polymorphism and DR. Materials and methods: This case-control study comprised 107 patients with type 1 diabetes mellitus (T1DM) and DR (cases) and 129 patients with T1DM without DR (controls) and with ≥ 10 years of DM. The ANGPT-2 rs2442598 (G/A) polymorphism was genotyped by real-time PCR using TaqMan [...] ABSTRACT Objective: As studies have reported the involvement of angiopoietin-2 (ANGPT-2) in the pathogenesis of diabetic retinopathy (DR), the aim of this study was to investigate the association between the ANGPT-2 rs2442598 polymorphism and DR. Materials and methods: This case-control study comprised 107 patients with type 1 diabetes mellitus (T1DM) and DR (cases) and 129 patients with T1DM without DR (controls) and with ≥ 10 years of DM. The ANGPT-2 rs2442598 (G/A) polymorphism was genotyped by real-time PCR using TaqMan

17 January 2022 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
CDCristine Dieter
Cristine Dieter
NLNatália E. Lemos
Natália E. Lemos
NCNathalia Rodrigues de Faria Corrêa
Nathalia Rodrigues de Faria Corrêa
FPFelipe Mateus Pellenz
Felipe Mateus Pellenz
LCLuís Henrique Canani
Luís Henrique Canani
ABAndrea C. Bauer
Andrea C. Bauer
Objective: The AKR1B1 gene encodes an enzyme that catalyzes the reduction of glucose into sorbitol. Chronic hyperglycemia in patients with diabetes mellitus (DM) leads to increased AKR1B1 affinity for glucose and, consequently, sorbitol accumulation. Elevated sorbitol increases oxidative stress, which is one of the main pathways related to chronic complications of diabetes, including diabetic kidney disease (DKD). Accordingly, some studies have suggested the rs759853 polymorphism in the AKR1B1 gene is associated with DKD; however, findings are still contradictory. The [...] ABSTRACT Objective: The AKR1B1 gene encodes an enzyme that catalyzes the reduction of glucose into sorbitol. Chronic hyperglycemia in patients with diabetes mellitus (DM) leads to increased AKR1B1 affinity for glucose and, consequently, sorbitol accumulation. Elevated sorbitol increases oxidative stress, which is one of the main pathways related to chronic complications of diabetes, including diabetic kidney disease (DKD). Accordingly, some studies have suggested the rs759853 polymorphism in the AKR1B1 gene is associated with DKD; however, findings are still contradictory. The

30 May 2023 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
CDCristine Dieter
Cristine Dieter
NLNatália E. Lemos
Natália E. Lemos
NCNathalia Rodrigues de Faria Corrêa
Nathalia Rodrigues de Faria Corrêa
TATaís Assmann
Taís Assmann
FPFelipe Mateus Pellenz
Felipe Mateus Pellenz
DCDaisy Crispim
Daisy Crispim
Objective: The objective of this study was to investigate the association between SNPs in the TIE2 and ANGPT-1 genes and diabetic retinopathy (DR). Subjects and methods: This study comprised 603 patients with type 2 diabetes mellitus (T2DM) and DR (cases) and 388 patients with T2DM for more than 10 years and without DR (controls). The TIE2 rs639225 (A/G) and rs638203 (A/G) SNPs and the ANGPT-1 rs4324901 (G/T) and rs2507800 (T/A) SNPs were genotyped by real-time PCR using TaqMan MGB [...] ABSTRACT Objective: The objective of this study was to investigate the association between SNPs in the TIE2 and ANGPT-1 genes and diabetic retinopathy (DR). Subjects and methods: This study comprised 603 patients with type 2 diabetes mellitus (T2DM) and DR (cases) and 388 patients with T2DM for more than 10 years and without DR (controls). The TIE2 rs639225 (A/G) and rs638203 (A/G) SNPs and the ANGPT-1 rs4324901 (G/T) and rs2507800 (T/A) SNPs were genotyped by real-time PCR using TaqMan MGB